The effect of intravitreal bevacizumab injection before Ahmed valve implantation in patients with neovascular glaucoma.

Published on Aug 1, 2014in International Ophthalmology1.314
· DOI :10.1007/S10792-013-9875-7
Jung Youb Kang2
Estimated H-index: 2
(Kosin University),
Ki Yup Nam10
Estimated H-index: 10
(Kosin University)
+ 1 AuthorsSeung Uk Lee6
Estimated H-index: 6
(Kosin University)
Sources
Abstract
To evaluate the effect of intravitreal bevacizumab (IVB) before Ahmed valve implantation for treatment of neovascular glaucoma (NVG). This study is a retrospective, comparative, consecutive case series. The study group consisted of 27 eyes of 26 patients with NVG who underwent an Ahmed valve implantation. Thirteen eyes were treated with Ahmed valve implantation alone (control group), and 14 eyes were treated with a combination of preoperative IVB injection and Ahmed valve implantation (IVB group). Visual acuity, intraocular pressure (IOP), number of anti-glaucoma medications, surgical complications, and success rate were compared between the two groups. There were no significant differences in preoperative characteristics between the two groups. Visual acuity at 1, 2 weeks, and 1 month after surgery were significantly better in the IVB group (p = 0.038, 0.034, and 0.032, respectively). Hyphema associated with Ahmed valve implantation occurred significantly less in the IVB group (p = 0.016). On the other hand, the mean IOP and number of anti-glaucoma medications at all follow-up periods were similar between the two groups. Kaplan–Meier survival analysis showed the probability of success 6 months after surgery as 71.4 % in the IVB group and 84.6 % in the control group. No significant difference in success rate was found between the groups (p = 0.422). IVB before Ahmed valve implantation for treatment of NVG reduced the incidence of hyphema. In this retrospective study, IVB provided better visual outcome in the early postoperative periods but did not significantly improve mean IOP, number of anti-glaucoma medications, or success rate.
📖 Papers frequently viewed together
23 Citations
18 Citations
25 Citations
References23
Newest
#1Kyoung Tak MaH-Index: 11
#2Jong Yun YangH-Index: 3
Last. Chan Yun KimH-Index: 31
view all 8 authors...
PURPOSE: To investigate the surgical results of Ahmed valve implantation with intraoperative bevacizumab injection in patients with neovascular glaucoma (NVG). METHODS: A retrospective comparative case series review was conducted on 52 eyes with NVG who underwent Ahmed glaucoma valve implantation with or without intraoperative bevacizumab intravitreal injection. In the intraoperative intravitreous bevacizumab injection group (IVB group, 20 eyes), 1.25 mg of bevacizumab was injected into the vitr...
25 CitationsSource
#1Noriko Yoshida (Kyushu University)H-Index: 12
#2Toshio Hisatomi (Kyushu University)H-Index: 48
Last. Tatsuro Ishibashi (Kyushu University)H-Index: 77
view all 9 authors...
Background Neovascular glaucoma (NVG) is a serious complication for patients with proliferative diabetic retinopathy (PDR). Bevacizumab is a full-length humanized monoclonal antibody that binds all isoforms of vascular endothelial growth factor (VEGF). Recently, encouraging results regarding the off-label use of intravitreal bevacizumab (IVB) for the treatment of NVG have been reported. We evaluated the histology of bevacizumab-treated trabeculectomy specimens to clarify IVB’s biological effects...
8 CitationsSource
#1Yuji Takihara (Kumamoto University)H-Index: 18
#2Masaru InataniH-Index: 26
Last. Hidenobu TaniharaH-Index: 58
view all 7 authors...
PURPOSE: To evaluate the effects of intravitreal bevacizumab (IVB) before mitomycin C trabeculectomy (MMCT) for neovascular glaucoma (NVG). METHODS: The study is a retrospective, comparative, consecutive case series. The study group consisted of 57 eyes from 50 patients with NVG who underwent a first MMCT: 33 eyes were treated with MMCT alone between June 1, 2005 and May 17, 2007 (Control Group); and, 24 eyes were treated with a combination of IVB and MMCT after May 18, 2007 (IVB Group). Surgica...
37 CitationsSource
#1Julia Beutel (University of Lübeck)H-Index: 3
#1Julia Beutel (University of Lübeck)H-Index: 11
Last. Salvatore Grisanti (University of Lübeck)H-Index: 24
view all 8 authors...
. Purpose: We aimed to evaluate the longterm effects of intraocular bevacizumab (Avastin®) injections as adjuvant treatment in patients with neovascular glaucoma. Methods: Twenty eyes of 18 consecutive patients with secondary neovascular glaucoma caused by proliferative diabetic retinopathy (n = 7), ischaemic central retinal vein occlusion (n = 7), ischaemic ophthalmopathy (n = 2) and retinal ischaemia resulting from persistent detachment (n = 2) were treated with intraocular bevacizumab injecti...
90 CitationsSource
#1Shahin YazdaniH-Index: 31
#2Kamran HendiH-Index: 2
Last. Mehdi YaseriH-Index: 41
view all 5 authors...
Purpose To determine the effect of intravitreal bevacizumab (IVB) on neovascular glaucoma (NVG) in terms of iris neovascularization (NVI), intraocular pressure (IOP), and visual acuity. Methods This randomized controlled trial included 26 eyes of 26 patients with NVG. All eyes received conventional treatment for NVG and were randomly allocated to three 2.5 mg IVB injections at 4-week intervals or a sham procedure (subconjunctival normal saline) at similar time intervals and in the same setting. ...
86 CitationsSource
Abstract Objective: To study the safety and efficacy of intravitreal injection of bevacizumab followed by aqueous shunting tube surgery for the management of neovascular glaucoma (NVG). Study Design: A prospective, non-randomized study with a historical control group. Participants: Twenty eyes of 20 patients with intractable NVG were treated with intravitreal injection of bevacizumab followed by aqueous shunting surgery (IVB group). A historical group of 10 NVG eyes treated with panretinal photo...
32 CitationsSource
#1Alexei L Moraczewski (Bascom Palmer Eye Institute)H-Index: 1
#2Richard K. LeeH-Index: 30
Last. William J. FeuerH-Index: 95
view all 5 authors...
Background/aims: To evaluate the course of treatment and outcomes of neovascular glaucoma (NVG) treated with intravitreal bevacizumab. Methods: The study is a retrospective, non-comparative, consecutive, interventional case series. Demographic data, past ocular history, cause of NVG, and anterior chamber angle status were recorded. Visual acuity (VA), intraocular pressure (IOP), number of IOP-lowering medications, and type of treatment administered were recorded at time of NVG diagnosis and at f...
88 CitationsSource
#1Taku Wakabayashi (Osaka University)H-Index: 18
#2Yusuke Oshima (Osaka University)H-Index: 30
Last. Yasuo Tano (Osaka University)H-Index: 89
view all 10 authors...
Purpose To evaluate the biologic efficacy of intravitreal bevacizumab (IVB) for iris neovascularization (INV) or neovascular glaucoma (NVG) in patients with ischemic retinal disorders. Design Retrospective, consecutive, interventional case series. Participants Thirty patients (41 eyes) with INV or NVG secondary to ischemic retinal disorders. Methods Patients received IVB (1 mg) as the initial treatment for INV or NVG and were followed up for at least 6 months. Ophthalmic evaluations included mea...
232 CitationsSource
#1Figen Batıoğlu (Ankara University)H-Index: 17
#2Neslihan Astam (Ankara University)H-Index: 2
Last. Emin Özmert (Ankara University)H-Index: 14
view all 3 authors...
Background Intravitreal injections of bevacizumab have been reported to have anatomical and functional success in treating choroidal neovascularization, macular edema and neovascular glaucoma. We report a case with neovascular glaucoma due to central retinal vein occlusion who demonstrates rapid resolution of anterior and posterior segment neovascularization after a single intravitreal bevacizumab injection. Case A 46-year old man with a 6-month history of central retinal vein occlusion presente...
51 CitationsSource
Objective: T o report the short-term efficacy and safety of intravitreal Bevacizumab injection in conjunction with implantation of Ahmed glaucoma valve in a patient with refractory neovascular glaucoma (NVG) caused by proliferative diabetic retinopathy (PDR). Material and Method: A patient with NVG and vitreous hemorrhage caused by PDR was initially treated with 1.25 mg intravitreal Bevacizumab injection. One week after injection, intraocular pressure (IOP) did not improve with partial regressio...
15 Citations
Cited By18
Newest
PURPOSE To evaluate the effects of subconjunctival bevacizumab injection on intraocular pressure (IOP), hypertensive phase, and failure and success rates of Ahmed Glaucoma Valve (AGV) implantation. METHODS A total of 63 eyes of 63 patients (30 cases in control and 33 cases in bevacizumab group) were included in this randomized masked prospective clinical trial. Pre- and postoperative BCVA, IOP, number of medications, complications and success rates were compared between AGV + bevacizumab and AGV...
Source
#1Zhan XieH-Index: 1
#2Hai Liu (Kunming Medical University)H-Index: 1
Last. Hong SunH-Index: 6
view all 8 authors...
To evaluate the efficacy of Ahmed glaucoma valve (AGV) implantation in treating neovascular glaucoma (NVG) and analyze the factors influencing the surgical success rate, a retrospective investigation of 59 NVG patients (66 eyes) who underwent AGV implantation was conducted at Jiangsu Province Hospital, China, from January 2014 to June 2018. Intraocular pressure (IOP), visual acuity, surgical success rates, medications, and complications were monitored at post-operative 1 day, 1 week, 1, 3, 6 and...
7 CitationsSource
#1Ying Hong (PKU: Peking University)H-Index: 1
#2Yuntao Hu (THU: Tsinghua University)H-Index: 1
Last. Zhizhong Ma (PKU: Peking University)H-Index: 9
view all 6 authors...
To compare the efficacy and safety of triple therapy combining intravitreal injection of anti-vascular endothelial growth factor, trabeculectomy, and pan-retinal photocoagulation via binocular indirect ophthalmoscopy, with that of transscleral cyclophotocoagulation (TCP) to treat neovascular glaucoma in the angle-closure stage. Eighteen triple therapy patients and 25 TCP patients between May 2014 and May 2016 were retrospectively analysed. Anterior chamber puncture and anti-VEGF intravitreal inj...
Source
#1Rajen Tailor (UCL Institute of Ophthalmology)H-Index: 2
#2Matt T. Kinsella (UCL Institute of Ophthalmology)H-Index: 1
Last. Jonathan Clarke (UCL Institute of Ophthalmology)H-Index: 4
view all 3 authors...
ABSTRACTBackground: To report the outcome of intravitreal Bevacizumab followed by Ahmed valve implantation in the management of neovascular glaucoma in a patient group with extended follow-up. Methods: The records of 16 patients (18 eyes) with neovascular glaucoma refractory to medical therapy who presented to a single surgeon between 2006–2008 were reviewed. Patients received pan-retinal photocoagulation and then intravitreal Bevacizumab followed by Ahmed valve implantation. The main outcome me...
3 CitationsSource
#1Fei You (Anhui Medical University)
#2Shouling Li (Anhui Medical University)
Abstract This article has been withdrawn at the request of the author(s) and/or editor. The Publisher apologizes for any inconvenience this may cause. The article can be found here: https://doi.org/10.1016/j.ijso.2017.11.006. The full Elsevier Policy on Article Withdrawal can be found at http://www.elsevier.com/locate/withdrawalpolicy.
Source
#1Ye He (CSU: Central South University)H-Index: 4
#2Ying TianH-Index: 4
Last. Xiaobo XiaH-Index: 14
view all 6 authors...
: This study aimed to evaluate the efficacy of Ahmed glaucoma valve (AGV) implantation in treating neovascular glaucoma (NVG) and to analyze the factors influencing the surgical success rate.This is a retrospective review of 40 eyes of 40 NVG patients who underwent AGV implantation at Xiangya Hospital of Central South University, China, between January 2014 and December 2016. Pre- and postoperative intraocular pressure (IOP), visual acuity, surgical success rate, medications, and complications w...
4 CitationsSource
#1Teng-Chieh Yu (NTNU: National Taiwan Normal University)H-Index: 1
#2Gow-Lieng TsengH-Index: 2
Last. Shiow-Wen LiouH-Index: 6
view all 4 authors...
RATIONALE: Neovascular glaucoma (NVG) is one of the most aggressive types of glaucoma, and its abnormal fibrovascular tissue growth on the iris and trabecular meshwork may create difficulties to control the intraocular pressure (IOP) and perform the operation such as trabeculectomy. PATIENT CONCERNS: Ex-PRESS glaucoma shunt has been introduced to serve as one alternative operation for glaucoma, and is thought to have the potential advantage of being less traumatic than traditional trabeculectomy...
4 CitationsSource
#1Junki Kwon (Asan Medical Center)H-Index: 8
#2Kyung Rim SungH-Index: 32
Purpose. To evaluate the effect of preoperative intravitreal bevacizumab (IVB) injection on the surgical outcome of Ahmed glaucoma valve (AGV) implantation according to the angle status in neovascular glaucoma (NVG) eyes. Materials and Methods. This retrospective study included 70 NVG patients who underwent AGV implantation and were followed up for at least 12 months. An IVB injection before AGV implantation was administered to 45 eyes (IVB group), while it was not administered to 25 eyes (contr...
6 CitationsSource
#1Minwen Zhou (SYSU: Sun Yat-sen University)H-Index: 1
#1Minwen Zhou (SYSU: Sun Yat-sen University)H-Index: 1
Last. Xiaodong SunH-Index: 1
view all 4 authors...
Purpose:To evaluate the efficacy and tolerability of Ahmed glaucoma valve (AGV) implantation with intravitreal bevacizumab injection (IVB) pretreatment in the treatment of neovascular glaucoma (NVG).Methods:A comprehensive literature search was performed according to the Cochrane collaboration metho
22 CitationsSource
#1Young Ho Jung (Seoul National University Hospital)H-Index: 7
#2Yong Woo KimH-Index: 12
Last. Jin Wook Jeoung (Seoul National University Hospital)H-Index: 28
view all 5 authors...
Source